At the end of April 2026, the federal government took a major step by moving FDA‑approved marijuana products and marijuana sold under qualifying state medical marijuana licenses from Schedule I to Schedule III of the Controlled Substances Act. This change recognizes accepted medical use and makes it easier to conduct clinical research, but it does
Starting with the 2026 tax year, the IRS will introduce a new form — Schedule 1-A — to capture several expanded deductions approved in the One Big Beautiful Bill Act (OBBA) that many taxpayers might overlook or might not claim. This new schedule allows individuals under certain income thresholds to report and deduct:Tips received from
The Cannabis industry had some rumors in the last few months on a potential move from Schedule I substance which are considered hard drugs with no medical use and that are especially harmful for users due to abuse to a more relaxed Schedule III which are medical drugs with lower dependence. The current Biden administration
